A month after filing lawsuits against one another, Warner Music Group (NYSE: WMG) and AnywhereCD have dropped the suits against each other and agreed to end the agreement they made early, on September 30 Billboard reports today. AnywhereCD is a website that sells both physical CD albums and digital albums, allowing consumers to download a Digital Rights Management technology-free MP3 version of a CD purchased on the site. The dispute began in late April when Warner terminated its agreement and requested that AnywhereCD remove all Warner content from the site because AnywhereCD gave consumers the option of purchasing only the DRM-free MP3 files. AnywhereCD subsequently sued for breach of content and defamation.
This news comes just days after Warner entered an agreement with Lala.com, a new internet music site that plans to sell music tracks that download directly to consumer's Apple Inc. (NASDAQ: AAPL) iPod's. The founders of Lala.com, formerly a site designed to allow consumers to trade CDs, intend to make the site into one that bypasses the traditional storage place for music files: a computer's hard drive. Warner is the only label so far that has licensed content to the site and their products will sell for $0.99 each (similar to iTunes?) and members can sample full tracks with Lala paying Warner one cent per sample play (iTunes offers only 30-second samples). Lala will also feature no advertisements or subscription fees and sell new CDs and continue to allow consumers to trade old CDs with each other for a $1 fee.
DRM will not play a role in the new site though, because Lala sells tracks that transfer directly to iPod, eliminating the chance that the average consumer can share files on peer-to-peer networks. This difference from a site like AnywhereCD likely made dropping DRM usage for Warner more feasible because the company still controls how the file is used.
Last updated: February 13, 2012: 01:09 PM
Hot Stocks
DailyFinance Headlines
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- On The Fly: Mid-Day Wrap
- Japan Airlines to invest Y500B in new planes, related spending, Nikkei reports
- Stocks with call strike movement; ZNGA BIDU
- NYSE market internals summary
- NASDAQ market internals summary
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
How State Taxes Put a Bigger Pinch on the Poor

